Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Miquel was a Spanish pharmaceutical company based in Barcelona, specializing in the development and commercialization of various therapeutic products, including respiratory and digestive health treatments. Founded in 1930, the company became a significant player in the Spanish pharmaceutical sector, particularly known for its pediatric digestive aid, Eupeptina. In 1991, the company was acquired by the German pharmaceutical group Madaus, which was later integrated into Rottapharm and subsequently acquired by Mylan (now Viatris). The company's legacy continues through its established brands, which remain active in the Spanish and international markets under the Viatris portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Miquel y Costas & Miquel.